Enteric Empty Capsules Market Size, Share and Growth Outlook, 2026

Enteric Empty Capsules Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Enteric Empty Capsules Market size is forecast to increase from $3.71 Billion in 2026 to $6 Billion in 2034 at a CAGR of 6.2% between 2026 and 2034.

The Enteric Empty Capsules market report provides detailed analysis and outlook of Enteric Empty Capsules segments including By Product Type (Gelatin-based Enteric Capsules, Non-Gelatin), By Raw Material Source (Animal-based, Plant & Fermentation-based ), By Functionality (Intrinsic Enteric Capsules, Delayed, pH-Sensitive), By Therapeutic Application (Antibiotic and Antibacterial Drugs, Vitamins and Health Supplements, Antacid and Antiflatulent Preparations, Probiotics and Gut Health Products, Cardiovascular Therapy), By End-User (Pharmaceutical Industry, Nutraceutical and Functional Food Industry, Cosmetic and Personal Care Industry, Contract Development & Manufacturing Organizations) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Enteric Empty Capsules Industry Overview

Acid-Resistant Enteric Capsule Technologies Enabling Early-Stage Drug Development

The enteric empty capsules industry is advancing through high-performance acid-resistant capsule technologies designed to improve gastrointestinal drug delivery precision and accelerate pharmaceutical development timelines. Lonza’s Capsules & Health Ingredients division launched its Capsugel® Enprotect® technology in an ultra-small “Size 9” hard capsule format specifically designed for pre-clinical rodent studies. The capsule uses an intrinsic acid-resistant polymer structure that bypasses gastric dissolution and releases its payload exclusively in the small intestine. This eliminates the need for separate enteric coating or sealing steps, enabling researchers to evaluate acid-sensitive molecules such as peptides, oral vaccines, and small molecules in their final dosage form at early development stages. The innovation supports more predictive pre-clinical outcomes by replicating human intestinal release behavior in small animal models, improving formulation screening efficiency and reducing development complexity in enteric drug delivery systems.

Coating-Free Enteric Capsules Accelerating Clinical Translation of Sensitive Therapeutics

The enteric empty capsules industry is increasingly focused on coating-free delivery systems that protect advanced therapeutics from gastric degradation while improving clinical trial readiness. Lonza scaled global manufacturing capacity for its Capsugel® Enprotect® hard empty capsule platform designed for human dosage applications. These capsules are engineered to protect live biotherapeutic products, RNA-based therapeutics, and acid-sensitive small molecules from stomach acid exposure, minimizing API degradation and improving bioavailability. The coating-free design reduces formulation complexity and shortens timeframes for first-in-human clinical trials by enabling direct encapsulation of sensitive compounds without additional protective layers. This advancement is particularly important for next-generation biologics and nucleic acid therapies, where stability during gastrointestinal transit is critical for therapeutic efficacy and clinical success.

Dual-Release Capsule-in-Capsule Systems Enhancing Targeted Intestinal Delivery

Innovation in enteric empty capsules is expanding toward advanced multi-compartment delivery systems designed for controlled release and site-specific gastrointestinal targeting. Lonza Capsugel published peer-reviewed research in collaboration with ProDigest validating its Licaps® DUOCAP® capsule-in-capsule technology. The study demonstrated that this dual-release format provides enhanced protection for acid-sensitive ingredients and achieves up to four times higher enzyme activity in the upper small intestine compared to standard immediate-release capsules. This system enables precise delivery of probiotics, enzymes, and other sensitive compounds to targeted regions of the gastrointestinal tract, improving therapeutic performance and functional ingredient stability. Capsule-in-capsule architectures are increasingly used to design sophisticated release profiles, supporting advanced nutraceutical and pharmaceutical formulations that require staged or region-specific absorption.

Advanced Blister and Sustainable Manufacturing Innovations in Solid Dosage Packaging

The enteric empty capsules and broader solid dosage packaging industry is evolving through innovations in protective packaging systems and sustainability-focused manufacturing practices. ACG Engineering launched SuperPod™, a cold-form blister technology designed to protect moisture-sensitive pharmaceutical and nutraceutical products by enhancing barrier properties and stability. This innovation strengthens product integrity for highly sensitive molecules requiring specialized containment conditions. In parallel, ACG Associated Capsules joined the United Nations Global Compact Network India, aligning its capsule manufacturing operations with global sustainability and ethical sourcing standards. This reflects an industry-wide transition toward environmentally responsible production processes in empty capsule manufacturing, supporting reduced environmental impact while maintaining stringent pharmaceutical-grade quality requirements.

Enteric Empty Capsules Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Enteric Empty Capsules market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Lonza Group AG (Capsugel / Enprotect), ACG Worldwide, Roquette Frères (Qualicaps), Suheung Co., Ltd., CapsCanada Corporation, Lefancaps Ltd., Roxlor LLC, Natural Capsules Limited (NCL), Sunil Healthcare Limited, AIPAK Pharmaceutical Equipment Co., Ltd.. The Enteric Empty Capsules market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Enteric Empty Capsules industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Enteric Empty Capsules Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Enteric Empty Capsules companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Enteric Empty Capsules markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Enteric Empty Capsules Market Competitive Benchmarking and Company Analysis

Leading companies in Enteric Empty Capsules industry include- Lonza Group AG (Capsugel / Enprotect), ACG Worldwide, Roquette Frères (Qualicaps), Suheung Co., Ltd., CapsCanada Corporation, Lefancaps Ltd., Roxlor LLC, Natural Capsules Limited (NCL), Sunil Healthcare Limited, AIPAK Pharmaceutical Equipment Co., Ltd.. The Enteric Empty Capsules market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Enteric Empty Capsules Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Enteric Empty Capsules market remains one of the strongest-performing segments in the country.
The US Enteric Empty Capsules Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Enteric Empty Capsules market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Enteric Empty Capsules industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Enteric Empty Capsules markets

Canada's strong Enteric Empty Capsules sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Enteric Empty Capsules market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Enteric Empty Capsules Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Enteric Empty Capsules market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Enteric Empty Capsules population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Enteric Empty Capsules industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Enteric Empty Capsules market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Enteric Empty Capsules sales through 2034

France Enteric Empty Capsules companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Enteric Empty Capsules Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Enteric Empty Capsules distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Enteric Empty Capsules Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Enteric Empty Capsules market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Enteric Empty Capsules industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Enteric Empty Capsules industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Enteric Empty Capsules Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Enteric Empty Capsules market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Enteric Empty Capsules market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Enteric Empty Capsules Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Enteric Empty Capsules Market Segmentation

By Product Type
Gelatin-based Enteric Capsules
Non-Gelatin
By Raw Material Source
Animal-based
Plant & Fermentation-based
By Functionality
Intrinsic Enteric Capsules
Delayed
pH-Sensitive
By Therapeutic Application
Antibiotic and Antibacterial Drugs
Vitamins and Health Supplements
Antacid and Antiflatulent Preparations
Probiotics and Gut Health Products
Cardiovascular Therapy
By End-User
Pharmaceutical Industry
Nutraceutical and Functional Food Industry
Cosmetic and Personal Care Industry
Contract Development & Manufacturing Organizations

Top Companies in Enteric Empty Capsules Industry

Lonza Group AG (Capsugel / Enprotect)
ACG Worldwide
Roquette Frères (Qualicaps)
Suheung Co., Ltd.
CapsCanada Corporation
Lefancaps Ltd.
Roxlor LLC
Natural Capsules Limited (NCL)
Sunil Healthcare Limited
AIPAK Pharmaceutical Equipment Co., Ltd.

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025